These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12517502)

  • 81. Edrecolomab in the adjuvant treatment of colorectal carcinoma.
    Spizzo G; Obrist P; Went P; Dirnhofer S; Gastl G
    Lancet; 2003 Jan; 361(9351):83; author reply 83. PubMed ID: 12517502
    [No Abstract]   [Full Text] [Related]  

  • 82. Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma.
    Schwartzberg LS
    Crit Rev Oncol Hematol; 2001 Oct; 40(1):17-24. PubMed ID: 11578913
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
    Graziano F; Catalano V; Baldelli AM; Cascinu S
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):247-57. PubMed ID: 12113030
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeted therapy in colorectal cancer.
    Wadler S
    Clin Colorectal Cancer; 2007 Jan; 6(5):357-61. PubMed ID: 17311700
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Monoclonal antibodies in the treatment of colorectal cancer.
    Veronese ML; O'Dwyer PJ
    Eur J Cancer; 2004 Jun; 40(9):1292-301. PubMed ID: 15177487
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Oncology 2010].
    Wörmann B
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1339-40. PubMed ID: 20556695
    [No Abstract]   [Full Text] [Related]  

  • 88. [Chemotherapy of patients with colorectal carcinoma].
    Punt CJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
    Beaven AW; Goldberg RM
    Oncology (Williston Park); 2006 Apr; 20(5):461-9; discussion 469-70, 473-5. PubMed ID: 16739745
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversies.
    Italiano A
    Oncology; 2006; 70(3):161-7. PubMed ID: 16675911
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Detection of hepatic micrometastases in the context of adjuvant chemotherapy and surgery for hepatic metastases].
    Schimanski CC; Möhler M; Zimmermann T; Gockel I; Lang H; Arbogast R; Jäger D; Galle PR; Berger MR
    Dtsch Med Wochenschr; 2010 May; 135(21):1078-82. PubMed ID: 20486059
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit?
    Eskens FA; Sleijfer S
    Eur J Cancer; 2008 Nov; 44(16):2350-6. PubMed ID: 18789679
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
    Medinger M; Steinbild S; Mross K
    Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Panitumumab in colorectal cancer.
    Wainberg ZA; Hecht JR
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):967-73. PubMed ID: 17627455
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
    Eng C; Abbruzzese JL
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Targeted therapy in colorectal carcinoma: more than a theory.
    Pickering L; Rudman S; Ross PJ; Leslie MD
    Colorectal Dis; 2008 Mar; 10(3):209-18; discussion 218-221. PubMed ID: 18257846
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treatment paradigms with epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Stein S; Cohen DJ; Hochster HS
    Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S44-50. PubMed ID: 20630850
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Introduction. Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancer.
    Díaz-Rubio E; Schmoll HJ
    Oncology; 2005; 69 Suppl 3():1-3. PubMed ID: 16301829
    [No Abstract]   [Full Text] [Related]  

  • 100. [Colorectal cancer: current treatment options].
    Graeven U; Andre N; Schmiegel W
    Z Gastroenterol; 2004 Dec; 42(12):1399-407. PubMed ID: 15592965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.